Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-08

Clinical Trial Update: Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating red yeast rice for lowering LDL cholesterol in dyslipidemia and LDL hyperlipoproteinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Red Yeast Rice (Monacolin K-containing red yeast rice)

Snippet

Sponsor: Saint-Joseph University | Conditions: Dyslipidemias, LDL Hyperlipoproteinemia | Phase 2 | Status: UNKNOWN